BNP Paribas Financial Markets Boosts Stock Holdings in VanEck Pharmaceutical ETF $PPH

BNP Paribas Financial Markets boosted its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 176.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 300,000 shares of the company’s stock after acquiring an additional 191,371 shares during the period. BNP Paribas Financial Markets owned 2.72% of VanEck Pharmaceutical ETF worth $30,951,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. AlphaCore Capital LLC purchased a new position in VanEck Pharmaceutical ETF during the fourth quarter valued at $31,000. IFP Advisors Inc grew its stake in shares of VanEck Pharmaceutical ETF by 53.7% in the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after buying an additional 153 shares in the last quarter. Advisory Services Network LLC purchased a new position in shares of VanEck Pharmaceutical ETF in the 3rd quarter worth $41,000. CWM LLC grew its stake in shares of VanEck Pharmaceutical ETF by 36.3% in the 4th quarter. CWM LLC now owns 511 shares of the company’s stock worth $53,000 after buying an additional 136 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its stake in shares of VanEck Pharmaceutical ETF by 64.7% in the 4th quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after buying an additional 282 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Up 3.4%

Shares of NASDAQ:PPH opened at $105.02 on Friday. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58. The stock has a market capitalization of $996.64 million, a P/E ratio of 20.21 and a beta of 0.47. The firm has a fifty day simple moving average of $102.62 and a two-hundred day simple moving average of $104.11.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 7th. Shareholders of record on Wednesday, April 1st were paid a $0.8441 dividend. This represents a $3.38 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Wednesday, April 1st. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.